These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21179937)

  • 1. Potential use of nanoparticle based contrast agents in MRI: a molecular imaging perspective.
    Oghabian MA; Farahbakhsh NM
    J Biomed Nanotechnol; 2010 Jun; 6(3):203-13. PubMed ID: 21179937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging by MRI.
    Winter PM; Caruthers SD; Wickline SA; Lanza GM
    Curr Cardiol Rep; 2006 Feb; 8(1):65-9. PubMed ID: 16507239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.
    Palekar RU; Jallouk AP; Lanza GM; Pan H; Wickline SA
    Nanomedicine (Lond); 2015; 10(11):1817-32. PubMed ID: 26080701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging of Brain Tumors Using Liposomal Contrast Agents and Nanoparticles.
    Mehta A; Ghaghada K; Mukundan S
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):751-763. PubMed ID: 27742115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.
    Yan Y; Sun X; Shen B
    Oncotarget; 2017 Jun; 8(26):43491-43505. PubMed ID: 28415647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy Monitoring with Functional and Molecular MR Imaging.
    García-Figueiras R; Padhani AR; Baleato-González S
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):261-288. PubMed ID: 26613885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From myocardium to the atherosclerotic plaque: new perspectives in cardiologic imaging].
    Gargiulo P; D'Amore C; Dellegrottaglie S; Leosco D; Rengo G; Musella F; Pirozzi E; Mosca S; Casaretti L; Formisano R; Bologna A; Parente A; Conte S; Perrone-Filardi P
    Monaldi Arch Chest Dis; 2011 Jun; 76(2):60-5. PubMed ID: 22128608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic nanoparticles for biomedical applications.
    Trahms L
    Biomed Tech (Berl); 2015 Oct; 60(5):389-91. PubMed ID: 26426885
    [No Abstract]   [Full Text] [Related]  

  • 9. Science to practice: will contrast agents for molecular imaging of angiogenesis help overcome the limitations of functional vascular imaging?
    Kiessling F
    Radiology; 2013 Aug; 268(2):309-11. PubMed ID: 23882090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular magnetic resonance contrast agents for the detection of cancer: past and present.
    Bogdanov A; Mazzanti ML
    Semin Oncol; 2011 Feb; 38(1):42-54. PubMed ID: 21362515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted magnetic resonance imaging contrast agents.
    Caruthers SD; Winter PM; Wickline SA; Lanza GM
    Methods Mol Med; 2006; 124():387-400. PubMed ID: 16506431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging in cardiovascular diseases.
    Botnar RM; Ebersberger H; Noerenberg D; Jansen CH; Wiethoff AJ; Schuster A; Kasner M; Walter TC; Knobloch G; Hoppe P; Diederichs G; Hamm B; Makowski MR
    Rofo; 2015 May; 36(2):92-101. PubMed ID: 25912326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrahigh field NMR and MRI: Science at a crossroads. Report on a jointly-funded NSF, NIH and DOE workshop, held on November 12-13, 2015 in Bethesda, Maryland, USA.
    Polenova T; Budinger TF
    J Magn Reson; 2016 May; 266():81-6. PubMed ID: 26860552
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular imaging in cardiovascular diseases.
    Botnar RM; Ebersberger H; Noerenberg D; Jansen CH; Wiethoff AJ; Schuster A; Kasner M; Walter TC; Knobloch G; Hoppe P; Diederichs G; Hamm B; Makowski MR
    Rofo; 2015 Feb; 187(2):92-101. PubMed ID: 25585260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.
    Wang L; Zhong X; Qian W; Huang J; Cao Z; Yu Q; Lipowska M; Lin R; Wang A; Yang L; Mao H
    J Magn Reson Imaging; 2014 Nov; 40(5):1071-81. PubMed ID: 25485347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques.
    Flacke S; Fischer S; Scott MJ; Fuhrhop RJ; Allen JS; McLean M; Winter P; Sicard GA; Gaffney PJ; Wickline SA; Lanza GM
    Circulation; 2001 Sep; 104(11):1280-5. PubMed ID: 11551880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and magnetic resonance imaging: The value of immunoliposomes.
    Kozlowska D; Foran P; MacMahon P; Shelly MJ; Eustace S; O'Kennedy R
    Adv Drug Deliv Rev; 2009 Dec; 61(15):1402-11. PubMed ID: 19796661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
    Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
    Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New technologies and directed agents for applications of cancer imaging.
    Atri M
    J Clin Oncol; 2006 Jul; 24(20):3299-308. PubMed ID: 16829654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.